Nucleic Acid Therapeutics CDMO Market, By Product Type (Standard Nucleic Acid, Micro-Scale Nucleic Acid, Large-Scale Nucleic Acid, Custom Nucleic Acid, Modified Nucleic Acid, Primers and Probes), By Chemical Synthesis (Solid-Phase Oligonucleotide Synthesis and Liquid-Phase Oligonucleotide Synthesis), By Technology (Column-Based Method and Microarray-Based Method), By Application (Oncology, Genetic Disorders and Infectious Diseases), By End-User (Pharmaceutical Companies, Academic Research Institute and Diagnostic Laboratories), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Nucleic Acid Therapeutics CDMO Market size was valued at USD 12,088 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.
A Nucleic Acid Therapeutics Contract Development and Manufacturing Organization (CDMO) is a specialized service provider in the biopharmaceutical industry. It is dedicated to the development and manufacturing of therapeutics that are based on nucleic acids. These therapeutics involve the use of DNA or RNA to modulate gene expression or target disease-causing genes. CDMOs that specialize in this field are essential for advancing the development and commercialization of these groundbreaking treatments. They offer expertise, infrastructure, and manufacturing capabilities that are specifically tailored to the unique requirements of nucleic acid-based drugs.
Nucleic Acid Therapeutics CDMO Market- Market Dynamics
- Progress in nucleic acid therapeutics, complex production processes, and increased funding are driving market growth.
Significant progress has been made in understanding of nucleic acid biology, as well as the development of various technologies such as mRNA, RNAi, antisense oligonucleotides, and gene editing (e.g., CRISPR-Cas9). These advancements have paved the way for a wide range of nucleic acid-based therapeutics. These drugs have shown effectiveness in treating various therapeutic areas, including oncology, infectious diseases, cardiovascular disorders, neurodegenerative diseases, and rare genetic conditions. In the field of oncology, RNA innovation has emerged as the second largest area of focus. Among the RNA technologies, mRNA holds the largest share in the pipeline with 32%, followed by ASOs with 29%, according to Clinical development landscape. Additionally, the COVID-19 pandemic has highlighted the significance of nucleic acid technologies, particularly mRNA vaccines, which have demonstrated remarkable efficacy within a relatively short period of time. Furthermore, the biopharmaceutical sector is witnessing increased investments, which is expected to create growth opportunities for the market. However, it is important to note that technical complexity and challenges in manufacturing scale-up may pose limitations to the market\'s growth.
Nucleic Acid Therapeutics CDMO Market- Key Insights
- As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2024-2032)
- Based on product type segmentation, Custom Nucleic Acid was predicted to show maximum market share in the year 2023
- Based on Chemical Synthesis segmentation, Solid-Phase Oligonucleotide Synthesis was the leading type in 2023
- Based on Technology segmentation, Column-Based Method was the leading type in 2023
- Based on Application segmentation, Oncology was the leading type in 2023
- Based on End-User segmentation, Academic Research Institutes was the leading type in 2023
- On the basis of region, North America was the leading revenue generator in 2023
Nucleic Acid Therapeutics CDMO Market- Segmentation Analysis:
The Global Nucleic Acid Therapeutics CDMO Market is segmented on the basis of Product Type, Chemical Synthesis, Technology, Application, End-User, and Region.
The market is segmented into eight groups according to the type of product: Standard Nucleic Acid, Micro-Scale Nucleic Acid, Large-Scale Nucleic Acid, Custom Nucleic Acid, Modified Nucleic Acid, Primers, Probes, and Other Nucleic Acid. Custom Nucleic Acid holds the largest share in the market. Furthermore, the Custom Nucleic Acid market is witnessing growth due to advancements in gene editing technologies, synthetic biology, and personalized medicine. Custom nucleic acids find applications in research, diagnostics, and therapeutic development.
The market is segmented into two groups according to Chemical Synthesis: Solid-Phase Oligonucleotide Synthesis and Liquid-Phase Oligonucleotide Synthesis. Solid-Phase Oligonucleotide Synthesis holds the majority share in the market. This method is commonly utilized for creating custom oligonucleotides, which are brief DNA or RNA molecules used for a variety of purposes such as research, diagnostics, and therapeutic applications.
The market is segmented into two categories according to Technology: Column-Based Method and Microarray-Based Method. The Column-Based Method segment holds the largest market share. These techniques facilitate the isolation and refinement of nucleic acids depending on their size, charge, and other physicochemical characteristics.
The market is segmented into three categories according to Application: Oncology, Genetic Disorders, Infectious Diseases, and Other. Oncology holds the largest market share. Contract Development and Manufacturing Organizations (CDMOs) are essential in facilitating the advancement and distribution of nucleic acid therapeutics in the field of oncology.
The market is segmented into three groups according to End-user: Pharmaceutical Companies, Academic Research Institutes, and Diagnostic Laboratories. Academic Research Institutes lead the market. Contract Development and Manufacturing Organizations collaborate closely with academic researchers to create scalable and cost-efficient manufacturing methods for nucleic acid therapeutics.
Nucleic Acid Therapeutics CDMO Market- Geographical Insights
This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by North America, primarily due to the increasing approvals of nucleic acid therapeutics by the FDA or European Medicines Agency (EMA). The FDA, in particular, plays a crucial role in the approval process of nucleic acid therapeutics in North America. The pharmaceutical industry in the United States employs over 1.3 million individuals, and there are more than 40,000 FDA-approved drugs available in the market, as per U.S. Pharmaceutical Statistics. Europe, on the other hand, holds the second-largest region for market growth, mainly due to the rising investments in biopharmaceuticals.
Nucleic Acid Therapeutics CDMO Market- Competitive Landscape:
The competition in the Nucleic Acid Therapeutics CDMO Market is intensifying as Contract Development and Manufacturing Organizations (CDMOs) work towards meeting the growing demand for innovative nucleic acid-based medications. To stay competitive in this industry, manufacturers need to focus on continuous innovation and investment in research and development (R&D). Additionally, establishing partnerships and collaborations with pharmaceutical companies, biotechs, academic institutions, and government agencies is essential for enhancing the market position of CDMOs. These collaborations provide access to new technologies, research discoveries, funding opportunities, and a wider network of partners. As an illustration, Eleven Therapeutics and Novo Nordisk have recently formed a research partnership to discover new nucleic acid molecules for treating cardiometabolic diseases using Eleven’s DELiveri platform.
Recent Developments:
- In January 2023, Catalent inaugurated a recently established large-scale plasmid DNA (pDNA) production plant at its European Center of Excellence for Cell Therapies in Gosselies, Belgium. The plant, spanning more than 12,000 ft2 (1,100 m2) of space for development and manufacturing within various cleanrooms dedicated to CGMP-grade pDNA manufacturing for clinical and commercial-phase distribution, has been meticulously crafted to adhere to EMA and FDA regulations in order to assist clients in need of efficient processes at 50 and 300-liter fermentation scale.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Catalent Inc.
- Thermo Fisher Scientific Inc.
- Lonza Group AG
- FUJIFILM Diosynth Biotechnologies Inc.
- Cognate BioServices Inc.
- Eurofins Genomics LLC
- Sirion Biotech GmbH
- Oxford Biomedica Plc.
- Danaher Corp.
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Standard Nucleic Acid
- Micro-Scale Nucleic Acid
- Large-Scale Nucleic Acid
- Custom Nucleic Acid
- Modified Nucleic Acid
- Primers
- Probes
- Other Nucleic Acid
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY CHEMICAL SYNTHESIS- MARKET ANALYSIS, 2019 - 2032
- Solid-Phase Oligonucleotide Synthesis
- Liquid-Phase Oligonucleotide Synthesis
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Column-Based Method
- Microarray-Based Method
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Genetic Disorders
- Infectious Diseases
- Others
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical Companies
- Academic Research Institute
- Diagnostic Laboratories
GLOBAL NUCLEIC ACID THERAPEUTICS CDMO MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Nucleic Acid Therapeutics CDMO Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Nucleic Acid Therapeutics CDMO Market Snippet by Product Type
2.1.2. Nucleic Acid Therapeutics CDMO Market Snippet by Chemical Synthesis
2.1.3. Nucleic Acid Therapeutics CDMO Market Snippet by Technology
2.1.4. Nucleic Acid Therapeutics CDMO Market Snippet by Application
2.1.5. Nucleic Acid Therapeutics CDMO Market Snippet by End User
2.1.6. Nucleic Acid Therapeutics CDMO Market Snippet by Country
2.1.7. Nucleic Acid Therapeutics CDMO Market Snippet by Region
2.2. Competitive Insights
3. Nucleic Acid Therapeutics CDMO Key Market Trends
3.1. Nucleic Acid Therapeutics CDMO Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Nucleic Acid Therapeutics CDMO Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Nucleic Acid Therapeutics CDMO Market Opportunities
3.4. Nucleic Acid Therapeutics CDMO Market Future Trends
4. Nucleic Acid Therapeutics CDMO Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Nucleic Acid Therapeutics CDMO Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Nucleic Acid Therapeutics CDMO Market Landscape
6.1. Nucleic Acid Therapeutics CDMO Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Nucleic Acid Therapeutics CDMO Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
7.1.2. Standard Nucleic Acid
7.1.3. Micro-Scale Nucleic Acid
7.1.4. Large-Scale Nucleic Acid
7.1.5. Custom Nucleic Acid
7.1.6. Modified Nucleic Acid
7.1.7. Primers
7.1.8. Probes
7.1.9. Other Nucleic Acid
8. Nucleic Acid Therapeutics CDMO Market – By Chemical Synthesis
8.1. Overview
8.1.1. Segment Share Analysis, By Chemical Synthesis, 2023 & 2032 (%)
8.1.2. Solid-Phase Oligonucleotide Synthesis
8.1.3. Liquid-Phase Oligonucleotide Synthesis
9. Nucleic Acid Therapeutics CDMO Market – By Technology
9.1. Overview
9.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
9.1.2. Column-Based Method
9.1.3. Microarray-Based Method
10. Nucleic Acid Therapeutics CDMO Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Chemical Synthesis, 2023 & 2032 (%)
10.1.2. Oncology
10.1.3. Genetic Disorders
10.1.4. Infectious Diseases
10.1.5. Others
11. Nucleic Acid Therapeutics CDMO Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
11.1.2. Pharmaceutical Companies
11.1.3. Academic Research Institute
11.1.4. Diagnostic Laboratories
12. Nucleic Acid Therapeutics CDMO Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. Italy
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. Italy Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.3.10.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. United Kingdom
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. United Kingdom Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.3.11.5. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.6. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. France
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. France Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.3.12.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Russia
12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.3. Russia Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.3.13.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. Netherlands
12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.3. Netherlands Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.3.14.4. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.5. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Poland
12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.3. Poland Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Rest of Europe
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Rest of the Europe Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Asia Pacific
12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. Asia Pacific Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.4.6. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.7. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. India
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. India Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.4.9.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. China
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. China Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.4.10.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Thailand
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Thailand Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.4.14.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Indonesia
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Indonesia Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.4.15.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America
12.5.1. Overview
12.5.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Latin America
12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. Latin America Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.5.6. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.7. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Nucleic Acid Therapeutics CDMO Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Chemical Synthesis, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Nucleic Acid Therapeutics CDMO Industry
13.1. Competitive Dashboard
13.2. Company Profiles
13.2.1. Catalent Inc.
13.2.2. Thermo Fisher Scientific Inc.
13.2.3. Lonza Group AG
13.2.4. FUJIFILM Diosynth Biotechnologies Inc.
13.2.5. Cognate BioServices Inc.
13.2.6. Eurofins Genomics LLC
13.2.7. Sirion Biotech GmbH
13.2.8. Oxford Biomedica Plc.
13.2.9. Danaher Corp.
13.2.10. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
